Herbert Smith Freehills has advised UBS AG, Hong Kong Branch; Citigroup Global Markets Asia Limited; and CITIC Securities Corporate Finance (HK) Limited in relation to their role as the underwriters and joint sponsors of the Initial Public Offering (IPO) of Luye Pharma Group Ltd. (“Luye”) and its listing on the Hong Kong Stock Exchange. The IPO raised US$764 million, making it the world’s largest pharmaceutical company IPO in three years.
Luye focuses on developing, producing and distributing innovative pharmaceutical products in three of China’s largest and fastest growing therapeutic areas: oncology, cardiovascular system and alimentary tract and metabolism.
Tags: Herbert Smith Freehills Kramer LLP







